CN104968360B - 用于治疗和/或护理皮肤、毛发和/或粘膜的化合物以及它们的化妆美容或药物组合物 - Google Patents

用于治疗和/或护理皮肤、毛发和/或粘膜的化合物以及它们的化妆美容或药物组合物 Download PDF

Info

Publication number
CN104968360B
CN104968360B CN201380072250.XA CN201380072250A CN104968360B CN 104968360 B CN104968360 B CN 104968360B CN 201380072250 A CN201380072250 A CN 201380072250A CN 104968360 B CN104968360 B CN 104968360B
Authority
CN
China
Prior art keywords
agents
inci
pharmaceutically acceptable
active
active agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380072250.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN104968360A (zh
Inventor
W·范登内斯特
塞莱玛 C·卡雷诺
冈萨雷斯 R·德尔加多
蒙铁尔 A·V·费雷尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lubrizol Advanced Materials Inc
Original Assignee
Lubrizol Advanced Materials Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lubrizol Advanced Materials Inc filed Critical Lubrizol Advanced Materials Inc
Publication of CN104968360A publication Critical patent/CN104968360A/zh
Application granted granted Critical
Publication of CN104968360B publication Critical patent/CN104968360B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/002—Preparations for repairing the hair, e.g. hair cure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
CN201380072250.XA 2012-12-05 2013-12-03 用于治疗和/或护理皮肤、毛发和/或粘膜的化合物以及它们的化妆美容或药物组合物 Active CN104968360B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12382484.9A EP2740484A1 (en) 2012-12-05 2012-12-05 Compounds useful in the treatment and/or care of the skin, hair and/or muccous membranes and their cosmetic or pharmaceutical compositions
EP12382484.9 2012-12-05
PCT/EP2013/075401 WO2014086785A1 (en) 2012-12-05 2013-12-03 Compounds useful in the treatent and/or care of the skin, hair and/or mucous membranes and their cosmetic or pharmaceutical compositions

Publications (2)

Publication Number Publication Date
CN104968360A CN104968360A (zh) 2015-10-07
CN104968360B true CN104968360B (zh) 2018-04-17

Family

ID=47749596

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380072250.XA Active CN104968360B (zh) 2012-12-05 2013-12-03 用于治疗和/或护理皮肤、毛发和/或粘膜的化合物以及它们的化妆美容或药物组合物

Country Status (11)

Country Link
US (1) US9511010B2 (enExample)
EP (2) EP2740484A1 (enExample)
JP (1) JP6522509B2 (enExample)
KR (1) KR102285933B1 (enExample)
CN (1) CN104968360B (enExample)
AU (1) AU2013354184C1 (enExample)
BR (1) BR112015012565B1 (enExample)
CA (1) CA2892905C (enExample)
ES (1) ES2869180T3 (enExample)
PL (1) PL2928484T3 (enExample)
WO (1) WO2014086785A1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2792684A1 (en) * 2013-04-15 2014-10-22 Lipotec, S.A. Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions
WO2015066647A2 (en) 2013-11-03 2015-05-07 The Regents Of The University Of California Ionic liquids for transdermal drug delivery
EP2990027A1 (en) * 2014-09-01 2016-03-02 Institut Curie Skin whitening peptide agents
US10242871B2 (en) * 2014-10-21 2019-03-26 Nissan Chemical Industries, Ltd. Resist underlayer film-forming composition including a compound having an amino group protected with a tert-butoxycarbonyl group
KR102481341B1 (ko) 2014-10-31 2022-12-23 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 피부 표면으로 활성 작용제의 전달을 위한 열가소성 폴리우레탄 필름
WO2016077817A1 (en) * 2014-11-14 2016-05-19 The General Hospital Corporation Methods and compositions for enhancing skin pigmentation
CN104523449A (zh) * 2015-01-08 2015-04-22 上海圣婕化妆品有限公司 一种抗衰老多胜肽复合物及其应用
CN104622779A (zh) * 2015-01-08 2015-05-20 上海圣婕化妆品有限公司 一种多胜肽抗衰老修复面膜精华液及其制备方法
US10722436B2 (en) 2015-08-10 2020-07-28 Mary Kay Inc. Topical compositions
WO2017079248A1 (en) 2015-11-05 2017-05-11 Lubrizol Advanced Materials, Inc. Thermoformable dual network hydrogel compositions
CN105362088B (zh) * 2015-12-22 2019-05-17 深圳市维琪医药研发有限公司 一种用于美白亮肤淡斑的多肽组合物
JP6808908B2 (ja) * 2016-01-19 2021-01-06 ポーラ化成工業株式会社 ジェル状化粧料
HK1257429A1 (zh) 2016-02-04 2019-10-18 ALASTIN Skincare, Inc. 用於侵入性和非侵入性程序性护肤的组合物和方法
KR101671812B1 (ko) * 2016-04-28 2016-11-02 주식회사 엘지생활건강 리퀴리틴을 유효성분으로 포함하는 체모 성장 억제용 조성물
CN106176274B (zh) * 2016-08-26 2020-04-10 深圳市维琪医药研发有限公司 一种具有抗敏作用的多肽组合物
WO2018044920A1 (en) 2016-08-29 2018-03-08 The Regents Of The University Of California Topical formulations based on ionic species for skin treatment
EP3532169A1 (en) * 2016-10-27 2019-09-04 DSM IP Assets B.V. Novel method
US10828265B2 (en) 2016-12-09 2020-11-10 The Regents Of The University Of California Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery
JP7191386B2 (ja) * 2017-02-24 2022-12-19 リポトゥルー，エセ．エレ． 化粧料に使用するためのペプチドおよび組成物
KR101971643B1 (ko) 2017-04-28 2019-04-24 주식회사 마크로케어 손상 모발 개선용 조성물 및 이의 제조방법
BR112020000123A2 (pt) * 2017-07-04 2020-07-07 Lubrizol Advanced Materials, Inc. composto, uso de um composto, composição cosmética, e, método para cuidado e/ou tratamento cosmético não terapêutico da pele, cabelos, unhas e/ou membranas mucosas
JP7340140B2 (ja) * 2017-07-20 2023-09-07 ダイヤ製薬株式会社 含水組成物、含水組成物を構成した貼付剤、化粧品又は外皮用医薬品、並びに、これらの製造方法
KR102757675B1 (ko) 2017-08-03 2025-01-20 앨러스틴 스킨케어, 인크. 피부 이완 및 신체 윤곽의 개선을 위한 조성물 및 방법
EP3761952B1 (en) * 2018-03-09 2024-08-14 Ocusoft, Inc. Topical skin care compositions
WO2020028694A1 (en) 2018-08-02 2020-02-06 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
WO2020142211A1 (en) 2019-01-02 2020-07-09 The Procter & Gamble Company Skin care compositions containing peptide compound and aphanothece sacrum exopolysaccharide extract
CN110420140B (zh) * 2019-07-16 2022-09-27 广州艾蓓生物科技有限公司 一种具有长效祛眼袋效果的祛眼袋霜及其制备方法
PL3831358T3 (pl) * 2019-12-04 2025-08-04 Lipotrue, S.L. Peptydy i kompozycje do stosowania w kosmetyce i medycynie
CN111358991B (zh) * 2020-03-24 2021-12-21 福建省海乐威生物工程有限公司 一种鞋袜除臭抗菌组合物及其制备方法
CN111632018B (zh) * 2020-06-12 2022-05-27 广东芭薇生物科技股份有限公司 一种含水解藻提取物的组合物及其应用
US20220110852A1 (en) * 2020-10-14 2022-04-14 Chanda Zaveri Pigment Stabilizers
US11771637B2 (en) 2021-01-22 2023-10-03 The Procter & Gamble Company Skin care composition and method of using the same
US11571378B2 (en) 2021-01-22 2023-02-07 The Procter & Gamble Company Skin care composition and method of using the same
BR102021015486A2 (pt) * 2021-08-05 2023-02-14 Aché Laboratórios Farmacêuticos S.A. Composição de nanopartícula lipídica contendo extrato de vitis vinifera, usos cosméticos de uma composição de nanopartícula lipídica contendo extrato de vitis vinifera, produto dermocosmético antioxidante e para prevenir o envelhecimento da pele e método de cuidado da pele
CN117659124A (zh) * 2021-11-25 2024-03-08 暨南大学 一类促进组织修复的新多肽及其应用
CN115364028B (zh) * 2022-09-19 2023-06-13 广州诺德丽诗化妆品有限公司 一种生物肽赋活修护面膜液及其制备方法
CN115581633B (zh) * 2022-10-14 2023-09-12 深圳市维琪科技股份有限公司 肽类化合物在制备用于皮肤延衰修复的组合物中的新用途
CN115804745B (zh) * 2022-12-27 2024-05-24 广州天然国度生物科技有限公司 一种皮肤护理舒缓修护组合物及其应用
CN116115548A (zh) * 2023-02-24 2023-05-16 配方化妆品科技(广州)有限公司 一种促毛囊、毛发生长的组合物及制备方法及应用
CN116196256B (zh) * 2023-03-17 2024-12-06 二元(苏州)工业科技有限公司 含精氨酸赖氨酸多肽的促渗透组合物及其制备方法和应用
CN117137851A (zh) * 2023-06-12 2023-12-01 华陈兴 一种含有美白组分的化妆品组合物
CN116751510B (zh) * 2023-07-10 2024-06-25 阿梓萨科技(深圳)有限公司 丙烯酸树脂复合纳米纤维素的光固化涂料的制备方法
CN118203650B (zh) * 2024-01-26 2025-04-29 上海萨丽斐生物科技有限公司 一种用于治疗色素沉着的药物

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004101607A2 (en) * 2003-05-13 2004-11-25 Hildebrand William H Comparative ligand mapping from mhc class i positive cells
WO2006012304A2 (en) * 2004-06-25 2006-02-02 The Salk Institute For Biological Studies Increasing life span by modulation of smek
US20060069049A1 (en) * 2003-12-29 2006-03-30 President And Fellows Of Harvard College Methods and reagents related to foxo
WO2007008982A2 (en) * 2005-07-11 2007-01-18 Irm Llc Methods and composition for modulating foxo1 activity and insulin signaling
US20090104177A1 (en) * 2004-06-29 2009-04-23 Forschungsverbund Berlin E.V. Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090062512A1 (en) * 2000-10-10 2009-03-05 Hildebrand William H Comparative ligand mapping from MHC class I positive cells
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
US20080107682A1 (en) * 2005-12-01 2008-05-08 Gireesh Rajashekara Brucella melitensis mutants and methods
ES2349972B1 (es) * 2009-02-16 2011-11-24 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosméticas o farmacéuticas.
ES2358829B1 (es) * 2009-10-23 2012-06-25 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cabello y su uso en composiciones cosméticas o farmacéuticas.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004101607A2 (en) * 2003-05-13 2004-11-25 Hildebrand William H Comparative ligand mapping from mhc class i positive cells
US20060069049A1 (en) * 2003-12-29 2006-03-30 President And Fellows Of Harvard College Methods and reagents related to foxo
WO2006012304A2 (en) * 2004-06-25 2006-02-02 The Salk Institute For Biological Studies Increasing life span by modulation of smek
US20090104177A1 (en) * 2004-06-29 2009-04-23 Forschungsverbund Berlin E.V. Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins
WO2007008982A2 (en) * 2005-07-11 2007-01-18 Irm Llc Methods and composition for modulating foxo1 activity and insulin signaling

Also Published As

Publication number Publication date
AU2013354184C1 (en) 2019-01-31
PL2928484T3 (pl) 2021-09-20
WO2014086785A1 (en) 2014-06-12
BR112015012565A2 (pt) 2017-09-12
EP2928484B1 (en) 2021-03-24
AU2013354184A1 (en) 2015-06-11
CA2892905C (en) 2023-08-15
JP6522509B2 (ja) 2019-05-29
EP2928484A1 (en) 2015-10-14
EP2740484A1 (en) 2014-06-11
ES2869180T3 (es) 2021-10-25
JP2016502550A (ja) 2016-01-28
BR112015012565B1 (pt) 2021-08-31
CA2892905A1 (en) 2014-06-12
KR102285933B1 (ko) 2021-08-04
US20150342852A1 (en) 2015-12-03
AU2013354184B2 (en) 2017-12-21
CN104968360A (zh) 2015-10-07
KR20150090922A (ko) 2015-08-06
US9511010B2 (en) 2016-12-06

Similar Documents

Publication Publication Date Title
CN104968360B (zh) 用于治疗和/或护理皮肤、毛发和/或粘膜的化合物以及它们的化妆美容或药物组合物
CN103379911B (zh) PGC-1α调节肽
CN108495646B (zh) 用于治疗和/或护理皮肤、毛发、指甲和/或粘膜的化合物
JP7227903B2 (ja) 皮膚、毛髪、爪および／もしくは粘膜の処置ならびに／またはケアに有用な化合物
CN104023737B (zh) 抑制被激活受体的肽及其在化妆品组合物或药物组合物中的用途
CN104254339B (zh) 用于治疗和/或护理皮肤和/或粘膜的化合物和它们在化妆品组合物或药物组合物中的用途
US11896704B2 (en) Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes
CN105408345A (zh) 用于治疗和/或护理皮肤的化合物及其化妆品或药物组合物
KR20120105450A (ko) 피부, 점막 및/또는 모발의 치료 및/또는 관리에 사용되는 펩티드 및 화장품학적 또는 약제학적 조성물에 있어서의 이의 용도
JP7526159B2 (ja) 皮膚、毛髪、爪および／または粘膜の処置および／またはケアに有用な化合物
KR20250052413A (ko) 피부, 모발, 손톱, 및/또는 점막의 처치 및/또는 관리에 유용한 화합물

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant